Analysts Set Enhabit, Inc. (NYSE:EHAB) Price Target at $13.57

Shares of Enhabit, Inc. (NYSE:EHABGet Free Report) have earned a consensus recommendation of “Hold” from the nine analysts that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and two have given a buy recommendation to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $13.5714.

Several analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft upgraded Enhabit to a “buy” rating in a report on Tuesday, January 13th. Oppenheimer lowered shares of Enhabit from an “outperform” rating to a “market perform” rating in a research note on Monday, February 23rd. Truist Financial set a $13.80 price objective on shares of Enhabit in a research report on Monday, February 23rd. Citigroup reissued a “buy” rating on shares of Enhabit in a research note on Tuesday, December 16th. Finally, Wolfe Research set a $12.00 target price on shares of Enhabit in a report on Thursday, January 8th.

Check Out Our Latest Stock Analysis on Enhabit

Insiders Place Their Bets

In other Enhabit news, EVP Julie Diane Jolley sold 2,793 shares of the firm’s stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $13.63, for a total value of $38,068.59. Following the completion of the sale, the executive vice president owned 139,923 shares of the company’s stock, valued at $1,907,150.49. This trade represents a 1.96% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 3.40% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the business. Hsbc Holdings PLC raised its holdings in shares of Enhabit by 56.6% in the fourth quarter. Hsbc Holdings PLC now owns 37,735 shares of the company’s stock worth $350,000 after buying an additional 13,633 shares during the period. Corient Private Wealth LLC boosted its holdings in Enhabit by 49.2% during the 4th quarter. Corient Private Wealth LLC now owns 14,967 shares of the company’s stock valued at $138,000 after acquiring an additional 4,933 shares during the period. Empowered Funds LLC grew its position in Enhabit by 11.1% in the 4th quarter. Empowered Funds LLC now owns 262,221 shares of the company’s stock valued at $2,418,000 after acquiring an additional 26,287 shares during the last quarter. Polymer Capital Management US LLC purchased a new stake in Enhabit in the fourth quarter worth $169,000. Finally, Eversept Partners LP purchased a new stake in Enhabit in the fourth quarter worth $2,015,000.

Enhabit Trading Up 0.1%

EHAB opened at $14.07 on Friday. The firm has a market cap of $713.38 million, a P/E ratio of -156.28 and a beta of 1.56. Enhabit has a 12 month low of $6.47 and a 12 month high of $14.22. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.76. The stock has a 50-day moving average of $12.40 and a 200 day moving average of $10.07.

Enhabit (NYSE:EHABGet Free Report) last issued its quarterly earnings data on Wednesday, March 4th. The company reported $0.14 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.14. The business had revenue of $270.40 million for the quarter, compared to the consensus estimate of $270.56 million. Enhabit had a positive return on equity of 4.71% and a negative net margin of 0.43%. As a group, research analysts forecast that Enhabit will post 0.22 EPS for the current year.

About Enhabit

(Get Free Report)

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.

Read More

Analyst Recommendations for Enhabit (NYSE:EHAB)

Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.